Immunomodulateurs et immunosuppresseurs pour la sclérose en plaques récurrente-rémittente : une méta-analyse en réseau https://t.co/PCyyPVPVpr
@cochranecollab Immunomodulators and immunosuppressants for relapsing-remitting multiple sclerosis: a network MA https://t.co/RVF6HFgT0J
RT @CochraneLibrary: MT @tlassers: Nodes, networks & new insights: different drug therapies in #MS compared by new #CochraneReview http://t…
RT CochraneLibrary MT tlassers: Nodes, networks & new insights: different drug therapies in #MS compared by new #C… http://t.co/XUOhIop6D8
MT @tlassers: Nodes, networks & new insights: different drug therapies in #MS compared by new #CochraneReview http://t.co/foMHDwBWcO
RT @AETSA_: #Rev_Sist #Cochrane #NMA de los tratamientos para #Esclerosis_múltiple recidivante recurrente http://t.co/1ZV9c6G66n @seneurolo…
RT @AETSA_: #Rev_Sist #Cochrane #NMA de los tratamientos para #Esclerosis_múltiple recidivante recurrente http://t.co/1ZV9c6G66n @seneurolo…
#Rev_Sist #Cochrane #NMA de los tratamientos para #Esclerosis_múltiple recidivante recurrente http://t.co/1ZV9c6G66n @seneurologia @sefh_
Immunomodulators and immunosuppressants for relapsing-remitting multiple sclerosis: a network meta-analysis. http://t.co/IuaU0LONV0
Nodes, networks & new insights: different drug therapies in #MS compared by new @CochraneLibrary review http://t.co/GiG1cnMwjB